Literature DB >> 23892367

RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.

Y Dondelinger1, M A Aguileta, V Goossens, C Dubuisson, S Grootjans, E Dejardin, P Vandenabeele, M J M Bertrand.   

Abstract

Receptor-interacting protein kinase (RIPK) 1 and RIPK3 have emerged as essential kinases mediating a regulated form of necrosis, known as necroptosis, that can be induced by tumor necrosis factor (TNF) signaling. As a consequence, inhibiting RIPK1 kinase activity and repressing RIPK3 expression levels have become commonly used approaches to estimate the contribution of necroptosis to specific phenotypes. Here, we report that RIPK1 kinase activity and RIPK3 also contribute to TNF-induced apoptosis in conditions of cellular inhibitor of apoptosis 1 and 2 (cIAP1/2) depletion or TGF-β-activated kinase 1 (TAK1) kinase inhibition, implying that inhibition of RIPK1 kinase activity or depletion of RIPK3 under cell death conditions is not always a prerequisite to conclude on the involvement of necroptosis. Moreover, we found that, contrary to cIAP1/2 depletion, TAK1 kinase inhibition induces assembly of the cytosolic RIPK1/Fas-associated protein with death domain/caspase-8 apoptotic TNF receptor 1 (TNFR1) complex IIb without affecting the RIPK1 ubiquitylation status at the level of TNFR1 complex I. These results indicate that the recruitment of TAK1 to the ubiquitin (Ub) chains, and not the Ub chains per se, regulates the contribution of RIPK1 to the apoptotic death trigger. In line with this, we found that cylindromatosis repression only provided protection to TNF-mediated RIPK1-dependent apoptosis in condition of reduced RIPK1 ubiquitylation obtained by cIAP1/2 depletion but not upon TAK1 kinase inhibition, again arguing for a role of TAK1 in preventing RIPK1-dependent apoptosis downstream of RIPK1 ubiquitylation. Importantly, we found that this function of TAK1 was independent of its known role in canonical nuclear factor-κB (NF-κB) activation. Our study therefore reports a new function of TAK1 in regulating an early NF-κB-independent cell death checkpoint in the TNFR1 apoptotic pathway. In both TNF-induced RIPK1 kinase-dependent apoptotic models, we found that RIPK3 contributes to full caspase-8 activation independently of its kinase activity or intact RHIM domain. In contrast, RIPK3 participates in caspase-8 activation by acting downstream of the cytosolic death complex assembly, possibly via reactive oxygen species generation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23892367      PMCID: PMC3770330          DOI: 10.1038/cdd.2013.94

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  49 in total

1.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

2.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.

Authors:  Jie Zhao; Siriporn Jitkaew; Zhenyu Cai; Swati Choksi; Qiuning Li; Ji Luo; Zheng-Gang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

3.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

Authors:  James E Vince; W Wei-Lynn Wong; Ian Gentle; Kate E Lawlor; Ramanjaneyulu Allam; Lorraine O'Reilly; Kylie Mason; Olaf Gross; Stephen Ma; Greta Guarda; Holly Anderton; Rosa Castillo; Georg Häcker; John Silke; Jürg Tschopp
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

4.  TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

Authors:  S Jouan-Lanhouet; M I Arshad; C Piquet-Pellorce; C Martin-Chouly; G Le Moigne-Muller; F Van Herreweghe; N Takahashi; O Sergent; D Lagadic-Gossmann; P Vandenabeele; M Samson; M-T Dimanche-Boitrel
Journal:  Cell Death Differ       Date:  2012-07-20       Impact factor: 15.828

5.  RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome.

Authors:  Linde Duprez; Nozomi Takahashi; Filip Van Hauwermeiren; Benjamin Vandendriessche; Vera Goossens; Tom Vanden Berghe; Wim Declercq; Claude Libert; Anje Cauwels; Peter Vandenabeele
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

6.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

7.  The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria.

Authors:  G M Kasof; J C Prosser; D Liu; M V Lorenzi; B C Gomes
Journal:  FEBS Lett       Date:  2000-05-19       Impact factor: 4.124

8.  IAPs limit activation of RIP kinases by TNF receptor 1 during development.

Authors:  Maryline Moulin; Holly Anderton; Anne K Voss; Tim Thomas; Wendy Wei-Lynn Wong; Aleksandra Bankovacki; Rebecca Feltham; Diep Chau; Wendy D Cook; John Silke; David L Vaux
Journal:  EMBO J       Date:  2012-02-10       Impact factor: 11.598

Review 9.  Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012.

Authors:  L Galluzzi; I Vitale; J M Abrams; E S Alnemri; E H Baehrecke; M V Blagosklonny; T M Dawson; V L Dawson; W S El-Deiry; S Fulda; E Gottlieb; D R Green; M O Hengartner; O Kepp; R A Knight; S Kumar; S A Lipton; X Lu; F Madeo; W Malorni; P Mehlen; G Nuñez; M E Peter; M Piacentini; D C Rubinsztein; Y Shi; H-U Simon; P Vandenabeele; E White; J Yuan; B Zhivotovsky; G Melino; G Kroemer
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

10.  NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1.

Authors:  Marie Anne O'Donnell; Hidenori Hase; Diana Legarda; Adrian T Ting
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

View more
  137 in total

1.  The combination of TPL2 knockdown and TNFα causes synthetic lethality via caspase-8 activation in human carcinoma cell lines.

Authors:  Oksana B Serebrennikova; Maria D Paraskevopoulou; Elia Aguado-Fraile; Vasiliki Taraslia; Wenying Ren; Geeta Thapa; Jatin Roper; Keyong Du; Carlo M Croce; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-25       Impact factor: 11.205

Review 2.  Developmental checkpoints guarded by regulated necrosis.

Authors:  Christopher P Dillon; Bart Tummers; Katherine Baran; Douglas R Green
Journal:  Cell Mol Life Sci       Date:  2016-04-07       Impact factor: 9.261

3.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke.

Authors:  Masanori Gomi Naito; Daichao Xu; Palak Amin; Jinwoo Lee; Huibing Wang; Wanjin Li; Michelle Kelliher; Manolis Pasparakis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

4.  When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157.

Authors:  Diego Rojas-Rivera; Tinneke Delvaeye; Ria Roelandt; Wim Nerinckx; Koen Augustyns; Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Cell Death Differ       Date:  2017-04-28       Impact factor: 15.828

Review 5.  SPATA2: more than a missing link.

Authors:  Lisa Schlicher; Prisca Brauns-Schubert; Florian Schubert; Ulrich Maurer
Journal:  Cell Death Differ       Date:  2017-03-10       Impact factor: 15.828

Review 6.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.

Authors:  Axel Witt; Domagoj Vucic
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

7.  Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis.

Authors:  Palak Amin; Marcus Florez; Ayaz Najafov; Heling Pan; Jiefei Geng; Dimitry Ofengeim; Slawomir A Dziedzic; Huibing Wang; Vica Jean Barrett; Yasushi Ito; Matthew J LaVoie; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

8.  A RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing.

Authors:  Kenta Moriwaki; John Bertin; Peter J Gough; Francis Ka-Ming Chan
Journal:  J Immunol       Date:  2015-01-07       Impact factor: 5.422

Review 9.  Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death.

Authors:  James M Murphy; John Silke
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

10.  TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging.

Authors:  Daichao Xu; Taijie Jin; Hong Zhu; Hongbo Chen; Dimitry Ofengeim; Chengyu Zou; Lauren Mifflin; Lifeng Pan; Palak Amin; Wanjin Li; Bing Shan; Masanori Gomi Naito; Huyan Meng; Ying Li; Heling Pan; Liviu Aron; Xian Adiconis; Joshua Z Levin; Bruce A Yankner; Junying Yuan
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.